Modulation of aryl hydrocarbon receptor (AHR) and the NAD(+)-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)

Author:

Bock, Karl Walter

Tübinger Autor(en):

Published in:

Biochemical Pharmacology (2020), Bd. 175, Article UNSP 113905

Verlagsangabe:

Pergamon - Elsevier Science Ltd

Language:

English

Full text:

ISSN:

1873-2968

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Artikel

This item appears in the following Collection(s)